Latest from all desks
API Connect – Building Stronger Industry Linkages in India’s API Sector
India’s Active Pharmaceutical Ingredient (API) industry is navigating a period of structural change. Global supply chain realignments, increasing emphasis on manufacturing resilience, evolving regulatory…
Arab Pharma Manufacturers’ Expo 2026 Set to Redefine the Region’s Pharmaceutical Manufacturing Landscape
250+ Exhibitors, High-Level Regulatory Delegations, and a Power-Packed Pharma Conference Mark the 8th Edition in Amman Amman, Jordan | July 1–2, 2026 The 8th…
FCE Pharma and FCE Cosmetique open visitor registration for their 30th edition
Events will take place simultaneously from June 1 to 3 and will showcase the main trends in the pharmaceutical and cosmetics industries NürnbergMesse Brasil…
6th Annual Pharma GMP & Quality Management 2026
Beyond Compliance: Building Trust Through Maturity April 23rd –24th, 2026 | Mumbai Pre-Event LinkedIn Live Series: March 20th – April 20th, 2026 | VirtualPost-Event…
Pharma Quality Excellence Awards 2026
Beyond Compliance: Building Quality Maturity. Recognizing organizations and leaders shaping mature GMP ecosystems In an era of heightened regulatory scrutiny, global supply chain complexity,…
TAF Connect 2026 to Host Launch of ASPA–CRISIL ‘State of Counterfeiting in India 2025’ Report in Mumbai
TAF Connect 2026: Trust. Track. Transform. The Authentication Solution Providers’ Association (ASPA) announces TAF Connect 2026 — Trust. Track. Transform., a high-impact, one-day national…
API Connect 2026: From Ingredients to Partnerships
Conversations around Active Pharmaceutical Ingredients are changing in subtle but important ways. As global pharmaceutical supply chains become more interlinked and regulatory expectations more…
CPHI and PMEC India by Informa Markets in India will transition into two specialised shows
From 2026 onward, CPHI and PMEC India by Informa Markets in India will transition into two specialised shows—CPHI at Dwarka and PMEC at IEML…
Get the Briefing, every Tuesday.
One email, every Tuesday morning. The signal from pharma's next decade — no noise, no reposts. Just curated, original editorial from Hello Pharma's newsroom.